1 – 10 of 30
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Exceptions and limitations (27 UPCA)
2023) p.109-128(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2022
-
Mark
Creative Machines, Orphan Inventions: AI and the concept of inventor at the EPO
2022) p.159-180(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2021
-
Mark
Big Science, Big Data, Big Innovation? : ERIC Policies on IP, Data and Technology Transfer
2021) p.65-106(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
The Role of Patents and Licensing in the Governance of Human Genome Editing: A White Paper
2021)(
- Book/Report › Report
- 2020
-
Mark
Patents, Morality and Biomedical Innovation in Europe : Historical overview, current debates on stem cells, gene editing and AI, and de lege ferenda reflections
2020) p.243-267(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2018
-
Mark
Cutting Edges and Weaving Threads in the Gene Editing (Я)evolution : Reconciling scientific progress with Legal, Ethical, & Social concerns
(
- Contribution to journal › Article
-
Mark
Patentability of human enhancement : From ethical dilemmas to legal (un)certainty
2018) p.54-92(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2017
-
Mark
Patenting Nanomedicine in Europe : Applying the 'medical methods exception' to emerging technologies
2017)(
- Book/Report › Book
- 2016
-
Mark
A “ray of hope” for European stem cell patents or “out of the smog into the fog”?
(
- Contribution to journal › Article
- 2015
-
Mark
The Impact of Broccoli II & Tomato II on European patents in conventional breeding, GMO’s and Synthetic Biology : The grand finale of a juicy patents tale?
(
- Contribution to journal › Article